Sweden· SE-20131221000051
Berinert 1500 IE Pulver och vätska till injektionsvätska, lösning
A medicinal product containing human c1-esterase inhibitor, registered in Sweden by CSL Behring GmbH.
Checked against Swedish Medical Products Agency (Sweden) on
Informational only — not a medical device.
The record
At a glance
Swedish Medical Products Agency (Sweden)- Active substance
- Human C1-Esterase Inhibitor
- Manufacturer
- CSL Behring GmbH
- Country
- Sweden (SE)
- ATC code
- —
- Reimbursed
- Not published by this register
- Source register
- Swedish Medical Products Agency (Sweden)
- Last checked
- October 1, 2026
Packs & prices · 1
- se_varunummer20131221000051
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Human c1-esterase inhibitor in 10 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- BelgiumBerinert 1500 IUCSL Behring
- NorwayBerinertCSL Behring GmbH (2)
- CzechiaBERINERTCSL Behring GmbH, Marburg
- United KingdomBerinert 1,500unit powder and solvent for solution for injection vialsCSL Behring UK Ltd
- IrelandBerinert 1500 IU Powder and solvent for solution for injectionCSL Behring GmbH
- IcelandBerinertCSL Behring GmbH*
- GermanyBerinertCsl Behring Gmbh
- CanadaBERINERT 1500CSL BEHRING CANADA INC
Authorised across Europe · EMA
The same active substance is authorised in 29 EEA countries. Names it is sold under:
- Austria · Berinert
- Belgium · Berinert
- Bulgaria · Беринерт
- Cyprus · Berinert
- Czechia · Berinert
- Germany · Berinert
- Denmark · Berinert
- Estonia · Berinert Iv, Berinert Sc
- Spain · Berinert
- Finland · Berinert
- France · Berinert
- United Kingdom (Northern Ireland) · Berinert
- Greece · Berinert
- Croatia · Berinert
- Hungary · Berinert
- Ireland · Berinert
- Iceland · Berinert, Cinryze
- Italy · Berinert
- Liechtenstein · Cinryze
- Lithuania · Human C1-Esterase Inhibitor Csl Behring
- Luxembourg · Berinert
- Malta · Berinert
- Netherlands · Berinert
- Norway · Berinert, Cinryze
- Poland · Berinert
- Portugal · Berinert
- Romania · Berinert
- Slovenia · Berinert
- Slovakia · Berinert
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Swedish Medical Products Agency (Sweden). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/648a9d9d-40ed-48eb-a2f8-b434414590a9 GET /v1/drugs/648a9d9d-40ed-48eb-a2f8-b434414590a9?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"source": "lakemedelsverket",
"doc_types": [
"PL",
"SmPC"
],
"se_npl_id": "20131221000051",
"product_page": "https://www.lakemedelsverket.se/sv/sok-lakemedelsfakta/lakemedel?id=20131221000051",
"product_doc_link": "https://docetp.mpa.se/LMF/Berinert%20500%20IU%201500%20IU%20powder%20and%20solvent%20for%20solution%20for%20injection%20or%20infusion%20SmPC_09001bee80ae4998.pdf"
}See everything about human c1-esterase inhibitor.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.